Christopher Cabell

Christopher Cabell

Director/Board Member bei PULMATRIX, INC.

Vermögen: 416 494 $ am 31.03.2024

54 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Christopher H.
Cabell
is currently the Director at ScienceMedia, Inc., Independent Director at Pulmatrix, Inc., and a Member of the American College of Cardiology Foundation.
He previously worked as the Co-Chairman at the US Food & Drug Administration and the Cardiac Safety Research Consortium.
He was also the Director-Echocardiography Core Lab at Duke Clinical Research Institute, Director at Cenduit LLC, and Senior Vice President-Global Access at Quintiles Transnational Corp.
He served as the Chief Medical & Scientific Officer at IQVIA, Inc. and IQVIA RDS, Inc. He was the Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. and is currently the Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. He was also an Associate Professor at Duke University School of Medicine.
He holds a graduate degree from Duke University and a doctorate from Duke University School of Medicine.
He also has an undergraduate degree from The Pennsylvania State University.
He will be the Chief Medical Officer & Executive Vice President at Zura Bio Ltd.
from 2023 to 2024.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.05.2023 162 060 ( 0,37% ) 416 494 $ 31.03.2024
25.03.2024 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Christopher Cabell

UnternehmenPositionBeginn
PULMATRIX, INC. Director/Board Member 23.06.2020
Director/Board Member 18.02.2020
Corporate Officer/Principal 30.04.2009
Alle aktiven Positionen von Christopher Cabell

Ehemalige bekannte Positionen von Christopher Cabell

UnternehmenPositionEnde
ZURA BIO LIMITED Chief Tech/Sci/R&D Officer 15.01.2024
EMERGENT BIOSOLUTIONS INC. Chief Tech/Sci/R&D Officer 01.01.2023
ARENA PHARMACEUTICALS Chief Tech/Sci/R&D Officer 01.12.2020
Chief Tech/Sci/R&D Officer 01.09.2017
Duke University School of Medicine Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Christopher Cabell im Detail an

Ausbildung von Christopher Cabell

Duke University Graduate Degree
The Pennsylvania State University Undergraduate Degree
Duke University School of Medicine Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christopher Cabell im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
EMERGENT BIOSOLUTIONS INC.

Health Technology

PULMATRIX, INC.

Health Technology

ZURA BIO LIMITED

Health Technology

Private Unternehmen10

Commercial Services

Technology Services

Health Technology

Health Technology

Government

Health Services

Commercial Services

Technology Services

Distribution Services

Cardiac Safety Research Consortium

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Christopher Cabell